News Formal

Asia-Pacific stocks set for mixed start; optimism rises on Pfizer vaccine approval

  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Pfizer and BioNTech's Covid-19 vaccine became the first in the U.S. on Monday to be granted full approval by the Food and Drug Administration.

Reuters reported that the U.S. Securities and Exchange Commission has began issuing new disclosure requirements to Chinese firms looking to list in New York.

SINGAPORE — Shares in Asia-Pacific looked set for a mixed start on Tuesday, after the tech-heavy Nasdaq Composite rose to a record closing high following theFutures pointed to a higher open in Japan. The Nikkei futures contract in Chicago was at 27,660 while its counterpart in Osaka was at 27,620. That compared against theAustralian stocks, on the other hand, looked poised for an opening slip.

 

コメントありがとうございます。コメントは審査後に公開されます。

Eyes on dua listed $BABA $JB $BIDU

good luck

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP

日本 最新ニュース, 日本 見出し